Diligence memo · auto-generated · as of July 2, 2026
ACON BioMatrix Investors I, L.L.C.
ACON BioMatrix Investors I, L.L.C. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
ACON BioMatrix Investors I, L.L.C. operates in Other Health Care, based in WASHINGTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
ACON BioMatrix Investors I, L.L.C. has raised $58M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $58M on 2016-11-17.
Most recent recorded round closed around 2016-11-17.
Valuation (modeled)modeled
Provath models ACON BioMatrix Investors I, L.L.C. at approximately $1.3B (range $209M–$3.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.26× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era. Within the normal band (126% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 9.6 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 93% of Other Health Care peers (5377 compared).
Modeled value ranks above 98% of those peers.
Closest niche peers: Specialty Networks, LLC, New MMI Holdings, Inc., BioMatrix Holdings, L.L.C., Sea Hunter Holdings, LLC, Bind Benefits, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.